Dr. Lobritz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Division Of Infectious Disease, Grj-504
Boston, MA 02114Phone+1 617-724-9248Fax+1 617-726-7653
Education & Training
- Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2011 - 2013
- Case Western Reserve University School of MedicineClass of 2009
Certifications & Licensure
- MA State Medical License 2013 - 2017
- CA State Medical License 2010 - 2011
Publications & Presentations
PubMed
- 1 citationsAuthor Correction: A new antibiotic traps lipopolysaccharide in its intermembrane transporter.Karanbir S Pahil, Morgan S A Gilman, Vadim Baidin, Thomas Clairfeuille, Patrizio Mattei
Nature. 2024-07-01 - Author Correction: A novel antibiotic class targeting the lipopolysaccharide transporter.Claudia Zampaloni, Patrizio Mattei, Konrad Bleicher, Lotte Winther, Claudia Thäte
Nature. 2024-07-01 - 36 citationsA new antibiotic traps lipopolysaccharide in its intermembrane transporter.Karanbir S Pahil, Morgan S A Gilman, Vadim Baidin, Thomas Clairfeuille, Patrizio Mattei
Nature. 2024-01-01
Press Mentions
- New Antibiotic Uses Novel Method to Target Deadly Drug-Resistant Bacteria, Study SaysJanuary 10th, 2024
- A Potent Antibiotic Has Emerged in the Battle Against Deadly, Drug-Resistant SuperbugsJanuary 10th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: